SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas

BACKGROUND: Diffuse gliomas, grades II and III, hereafter called lower-grade gliomas (LGG), have variable, difficult to predict clinical courses, resulting in multiple studies to identify prognostic biomarkers. The purpose of this study was to assess expression or methylation of the homeobox family...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu-An, Zhou, Yunyun, Luo, Xin, Song, Kai, Ma, Xiaotu, Sathe, Adwait, Girard, Luc, Xiao, Guanghua, Gazdar, Adi F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264450/
https://www.ncbi.nlm.nih.gov/pubmed/27840009
http://dx.doi.org/10.1016/j.ebiom.2016.10.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264450/
https://www.ncbi.nlm.nih.gov/pubmed/27840009
http://dx.doi.org/10.1016/j.ebiom.2016.10.040

Ejemplares similares